What is the Impact Factor of Cancer Nanotechnology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cancer Nanotechnology is 5.80, ranking in quartile Q2 of Web of Science (SCIE).

Is Cancer Nanotechnology indexed in Web of Science or Scopus?

Yes, Cancer Nanotechnology is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.849 (Q1) and an H-index of 46.

Who publishes Cancer Nanotechnology and what is the Article Processing Charge (APC)?

Cancer Nanotechnology is published by Springer Vienna. The estimated Article Processing Charge (APC) is approximately $3,208 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cancer Nanotechnology?

The official ISO-4 abbreviation of Cancer Nanotechnology is "CANCER NANOTECHNOL" with common acronym "cano". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #6,318Gold OA

Cancer Nanotechnology

Acronym:cano

•

Abbreviation (ISO):CANCER NANOTECHNOL

•

Identifier (ISSN):1868-6958(Print)/1868-6966(Online)

•

Publisher:Springer Vienna

Official Website Submission Portal Compare

Clarivate IF (2026)

5.8↑ +1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Cancer Nanotechnology

WoS Q2

Annual Impact Factor Metric

Current (2026):5.8

Scopus SJR & RankScopus Q1

0.849

#6,318

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

46 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate4.4%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

33articles/year

100% Gold OA•95.35% Original Research

Aims & Scope

Aim: Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas. Scope: Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

Topics Covered (Recognized by AI)

Biology91.5%Medicine86.2%Chemistry85.1%Genetics84%Materials science80.9%Physics76.1%Nanotechnology73.9%Internal medicine73.4%Engineering70.2%Biochemistry68.6%Quantum mechanics66%Chemical engineering60.6%Organic chemistry58.5%Nanoparticle55.9%Cancer52.7%In vitro37.8%Cancer research36.7%Pharmacology29.3%Surgery28.2%Apoptosis28.2%Cancer cell26.6%Drug delivery25.5%Optics25%Cell24.5%Cell culture23.4%Psychology23.4%Biophysics23.4%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics Pharmaceutical Science

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Rank57/148

IndexSCIE

JCRSCIE2026

ONCOLOGY

Rank67/333

IndexSCIE

JCISCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Rank45/148

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank102/333

IndexSCIE

Category	Index	Rank	Quartile
NANOSCIENCE & NANOTECHNOLOGY	JCRSCIE	57/148	Q2
ONCOLOGY	JCRSCIE	67/333	Q1
NANOSCIENCE & NANOTECHNOLOGY	JCISCIE	45/148	Q2
ONCOLOGY	JCISCIE	102/333	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.8

Articles / Year68

Total Citations21

2025

IF4.8

Articles / Year57

Total Citations373

2024

IF4.5

Articles / Year62

Total Citations807

2023

IF5.7

Articles / Year85

Total Citations1,397

2022

IF7.917

Articles / Year56

Total Citations753

Year	Impact Factor	Articles / Year	Total Citations
2026	5.8	68	21
2025	4.8	57	373
2024	4.5	62	807
2023	5.7	85	1,397
2022	7.917	56	753
2021	5.095	34	1,050
2020	4.7	15	474
2019	—	11	769
2018	—	11	608
2017	—	10	760
2016	—	11	793
2015	—	4	116

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,318Scopus Q1SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:ChemistryEngineeringMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.849

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

6.25

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,208 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,065

3-Year Documents181

Citable Documents181

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1

Physical and Theoretical ChemistryQ1

Biomedical EngineeringQ2

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cancer Nanotechnology (acronym: cano, abbr: CANCER NANOTECHNOL, ISSN: 1868-6958) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Springer Vienna in Austria since 2010. The periodical holds a Journal Impact Factor (JIF) of 5.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.849 (Q1), an H-index of 46.

The journal enforces rigorous peer evaluation with an annual output of approximately 33 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,208 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.